Sonoma Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview

Sonoma Pharmaceuticals

04/08/2025 22:43

Sonoma Pharmaceuticals Inc SNOA.OQ SNOA.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The Boulder Colorado-based  company is expected to report a 19.4% increase in revenue to $4.05 million from $3.39 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Sonoma Pharmaceuticals Inc is for a loss of 51 cents per share.

The one available analyst rating on the shares is "strong buy".

The average consensus recommendation for the pharmaceuticals peer group is also "Strong Buy".​

Wall Street's median 12-month price target for Sonoma Pharmaceuticals Inc is $14.80, about 79.2% above its last closing price of $3.09

This summary was machine generated August 4 at 21:43 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)